Axogen, Inc. Proceeds from Lines of Credit
Axogen, Inc. (AXGN) reported Proceeds from Lines of Credit of $0 for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-01.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromLinesOfCredit · last filed 2021-03-01
- Axogen, Inc. proceeds from lines of credit for the quarter ending 2018-12-31 was $0.00, a 100.00% decline year-over-year.
- Axogen, Inc. proceeds from lines of credit for the quarter ending 2018-09-30 was $0.00, a 100.00% decline year-over-year.
- Axogen, Inc. proceeds from lines of credit for the quarter ending 2018-06-30 was $10.11M, a 32.04% decline year-over-year.
- Axogen, Inc. proceeds from lines of credit for the quarter ending 2018-03-31 was $16.15M, a 43.56% increase year-over-year.
- Axogen, Inc. proceeds from lines of credit for fiscal 2020 was $0.00.
- Axogen, Inc. proceeds from lines of credit for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
- Axogen, Inc. proceeds from lines of credit for fiscal 2018 was $26.25M, a 54.42% decline from fiscal 2017.
- Axogen, Inc. proceeds from lines of credit for fiscal 2017 was $57.60M, a 761.62% increase from fiscal 2016.
| Period end | Proceeds from Lines of Credit 3 month | Proceeds from Lines of Credit 3 month as first filed | Proceeds from Lines of Credit 6 month | Proceeds from Lines of Credit 6 month as first filed | Proceeds from Lines of Credit 9 month | Proceeds from Lines of Credit 9 month as first filed | Proceeds from Lines of Credit 12 month | Proceeds from Lines of Credit 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2020-12-31 | $0.00 10-K · filed 2021-03-01 | |||||||
| 2019-12-31 | $0.00 10-K · filed 2021-03-01 | |||||||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $0.00 derived: sum of 2 quarters · filed 2021-03-01 | $10.11M derived: sum of 3 quarters · filed 2021-03-01 | $26.25M 10-K · filed 2021-03-01 | ||||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $10.11M derived: sum of 2 quarters · filed 2019-11-06 | $26.25M 10-Q · filed 2019-11-06 | $26.25M 10-Q · filed 2018-10-29 | $42.30M derived: sum of 4 quarters · filed 2020-02-24 | |||
| 2018-06-30 | $10.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $26.25M 10-Q · filed 2019-08-06 | $26.25M 10-Q · filed 2018-08-01 | $42.30M derived: sum of 3 quarters · filed 2020-02-24 | $57.73M derived: sum of 4 quarters · filed 2020-02-24 | |||
| 2018-03-31 | $16.15M 10-Q · filed 2019-05-08 | $16.15M 10-Q · filed 2018-04-30 | $32.19M derived: sum of 2 quarters · filed 2020-02-24 | $47.63M derived: sum of 3 quarters · filed 2020-02-24 | $62.50M derived: sum of 4 quarters · filed 2020-02-24 | |||
| 2017-12-31 | $16.05M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $31.48M derived: sum of 2 quarters · filed 2020-02-24 | $46.35M derived: sum of 3 quarters · filed 2020-02-24 | $57.60M 10-K · filed 2020-02-24 | $57.60M 10-K · filed 2018-02-28 | |||
| 2017-09-30 | $15.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-29 | $30.31M derived: sum of 2 quarters · filed 2018-10-29 | $41.55M 10-Q · filed 2018-10-29 | |||||
| 2017-06-30 | $14.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | $26.12M 10-Q · filed 2018-08-01 | ||||||
| 2017-03-31 | $11.25M 10-Q · filed 2018-04-30 | |||||||
| 2016-12-31 | $6.68M 10-K · filed 2019-02-26 | $6.68M 10-K · filed 2017-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |